Indivior (LON:INDV) Trading Down 1.2% – Time to Sell?

Indivior PLC (LON:INDV) shares were down 1.2% on Wednesday . The company traded as low as GBX 891 ($11.25) and last traded at GBX 897 ($11.32). Approximately 215,905 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 1,137,238 shares. The stock had previously closed at GBX 908 ($11.46).

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,500 ($18.93) price target on shares of Indivior in a research note on Thursday, September 5th.

Indivior Stock Down 1.4 %

The firm has a market capitalization of £1.17 billion, a PE ratio of -1,135.00, a P/E/G ratio of -5.57 and a beta of 0.19. The stock has a 50-day simple moving average of GBX 765.53 and a 200-day simple moving average of GBX 926.53. The company has a quick ratio of 1.52, a current ratio of 0.85 and a debt-to-equity ratio of 2,790.00.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.